美國Supernus Pharma
專注于癲癇等中樞神經系統治療的制藥公司Supernus Pharmaceuticals Inc。盡管Supernus研發的藥物迄今沒有一種獲得監管部門批準,而且也沒有從中賺得一分錢,但該公司擁有比傳統醫藥創業公司更豐富的經驗:它是于2005年在Shire Laboratories基礎上創建的,同時使用以前用過的相同專有技術系統開發已獲得批準并上市的治療手段。
With more than 20 years of experience, we are a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders.
We are developing several product candidates in neurology and psychiatry to address unmet medical needs and opportunities in epilepsy, attention-deficit hyperactivity disorder (ADHD) and its coexisting disorders, and depression.
We are developing differentiated products by leveraging our proprietary and in-licensed technologies. We use such technologies to discover and develop novel uses for known drug compounds and to enhance their therapeutic benefits. Our focus on known drug compounds with established mechanisms of action reduces the risks, costs, and time typically associated with pharmaceutical product development.